Delivery Order SPE2DB22D1017-SPE2DB25FG9VY
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,809.04 to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia management. This firm fixed-price contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,173.54 for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia management. This competitively awarded, firm fixed-price contract was executed on August 4, 2025, with a completion date of August 5, 2025, and carries no set-aside designation. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $51,938.18 delivery order to AmerisourceBergen Drug Corp for 60-tablet units of Multaq 400 mg tablets, a pharmaceutical product used in cardiac arrhythmia management. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure, with an ultimate completion date of August 13, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $5,713.28 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia management. This competitive award, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia management. This firm fixed-price delivery order, valued at $6,234.74, was awarded on August 12, 2025, with an ultimate completion date of August 13, 2025. The award utilized no set-aside provisions and was competitively awarded to AmerisourceBergen's Corporate Office, headquartered in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $3,200.00 for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia management. This was a competitively awarded, firm fixed-price delivery order with no set-aside designation, with performance completed by August 1, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,605.56 to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia management. The contract was awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, and utilized firm fixed pricing with no set-aside designation. This delivery order represents a competitive award under AmerisourceBergen's existing federal contract vehicle, reflecting the company's...
- The Defense Logistics Agency awarded a $3,350.95 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used to treat cardiac arrhythmias. This competitive, non-set-aside contract was awarded on August 11, 2025, with an ultimate completion date of August 12, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order utilizes firm fixed pricing and represents a child contract under the...
- The Defense Logistics Agency awarded a delivery order valued at $1,586.58 to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia management. This firm fixed-price contract was competitively awarded without set-aside designation and is set for completion by July 28, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia management. This competitively awarded, firm fixed-price delivery order, valued at $1,529.88, was executed on August 12, 2025, with an ultimate completion date of August 13, 2025. The contract carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG9VYDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,167.80 to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia treatment. The contract was competitively awarded without a set-aside designation and carries a firm fixed price structure, with an ultimate completion date of August 15, 2025. Performance of this delivery order is based in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a critical pharmaceutical distributor to federal medical procurement needs, AmerisourceBergen Drug Corp supplies medications and medical supplies to support military and veteran healthcare systems through this comprehensive global pharmaceutical support vehicle. The IDC enables the company to fulfill diverse pharmaceutical requirements across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.2k | 8/14/25 |